LATERAL NECK DISSECTION 4 th post-grad course in Endocrine Surgery 2012

Similar documents
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

Advances in Differentiated Thyroid Cancer

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科

THYROID CANCER. I. Introduction

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery

Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)

Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD

Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve,

Thyroid and Adrenal Gland

Thyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010

TNM Staging of Head and Neck Cancer and Neck Dissection Classification

Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare

Latest Oncologic Strategies for Well-Differentiated Thyroid Carcinoma

The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).

<1 cm WDT-UMP, FT-UMP. Kakudo K et al, Pathol Int,2009, Endocr J, 2011 and Pathol Int, 2012

The epidemic of thyroid cancer and its evolving management: Is less more?

BRAF as a prognostic marker in papillary thyroid cancer

IV. DEFINITION OF LYMPH NODE GROUPS (FIGURE 1) Level IA: Submental Group

Locoregional recurrence or persistence of papillary carcinoma: radioiodine treatment

Management of Differentiated Thyroid Carcinoma American Thyroid Association Guidelines and Data from Kaohsiung Chang Gung Memorial Hospital

Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma

Followup of Patients with Papillary Thyroid Cancer: In Search of the Optimal Algorithm

BRAF in the diagnostic evaluation of thyroid nodules

WELL DIFFERENTIATED THYROID CANCER

Papillary thyroid cancer accounts for approximately 90% Lymph Node Dissection in Papillary Thyroid Carcinoma

Oxford Centre for Head and Neck Oncology The Thyroid Gland and Thyroid Cancer Information for patients

Image SW Review the anatomy of the EAC and how this plays a role in the spread of tumors.

Current Treatment of Papillary Thyroid Microcarcinoma

Thyroid Cancer A Multidisciplinary Approach

Preventable reoperations for persistent and recurrent papillary thyroid carcinoma

Ilioinguinal dissection (removal of lymph nodes in the groin and pelvis)

13 Management of Cervical Lymph Nodes in Differentiated Thyroid Cancer

Understanding your pathology report

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid

Well-differentiated Thyroid Carcinoma: Factors Predicting Recurrence and Survival

Kidney Cancer OVERVIEW

Conflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.

Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Recommendations for cross-sectional imaging in cancer management, Second edition

OBJECTIVES By the end of this segment, the community participant will be able to:

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Lymph Node Dissection for Penile Cancer

Current Status and Perspectives of Radiation Therapy for Breast Cancer

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Prognostic and Predictive Factors in Oncology. Mustafa Benekli, M.D.

Pediatric Oncology for Otolaryngologists

Thyroid Surgery at Massachusetts General Hospital Frequently Asked Questions

Hosts. New Methods for Treating Colorectal Cancer

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Cervical Cancer The Importance of Cervical Screening and Vaccination

Challenges in gastric, appendiceal and rectal NETs Leuven,

X/97/$03.00/0 Vol. 82, No. 11 Journal of Clinical Endocrinology and Metabolism Copyright 1997 by The Endocrine Society

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

AACE/AAES MEDICAL/SURGICAL GUIDELINES FOR CLINICAL PRACTICE: MANAGEMENT OF THYROID CARCINOMA

Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds

Frequently Asked Questions About Ovarian Cancer

Thyroid Carcinoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version NCCN.org. Continue

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

Understanding Your Surgical Options For Breast Cancer

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

There are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.

Loco-regional Recurrence

D. FREQUENTLY ASKED QUESTIONS

Nicole Kounalakis, MD

One out of every two men and one out of every three women will have some type of cancer at some point during their lifetime. 3

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.

I Radiotherapy of Pediatric Thyroid Cancer

Endoscopic Therapy for Early Esophageal Cancer: EMR and ESD

Treating Melanoma S kin Cancer A Quick Guide

Thyroid Cancer. What is thyroid cancer? The thyroid gland

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.

Understanding Metastatic Disease

Anaplastic Thyroid Cancer:

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15

BREAST CANCER PATHOLOGY

Surgical Staging of Endometrial Cancer

Primary -Benign - Malignant Secondary

Overview of Gynaecologic Cancer

Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method

Cancer of the Thyroid Explained

The 2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Cancer: An Author s Perspective

PET/CT in Breast Cancer

Transcription:

LATERAL NECK DISSECTION 4 th post-grad course in Endocrine Surgery 2012 MAURICE STEVENS ( ENT, Head and Neck ) ROYAL BRISBANE AND WOMENS HOSPITAL Head and Neck Multidiciplinary Clinic

PAPILLARY THYROID CANCER FNA suspicious thyroid lumps 50-75% are malignant Metastatic disease at presentation 25-64% - not a potent adverse indicator of prog. - higher chance of locoregional recurr. - clinical incidence of recurr. is no> 10-20% when the neck is not surgically treated WHY? TSH suppress - RAI - fail to grow

PAPILLARY THYROID CANCER prognostic factors Tumour size Extrathyroidal spread Angiolymphatic invasion Multifocal Any positive lymph nodes BRAF mutation - more aggressive!

PAPILLARY THYROID CANCER Presence of LN mets. does affect prognosis The days of cherry picking are over Elective dissection in a clin./radiol. Neg. neck is highly controversial Post- op RAI is not always preferred ( Japan ) or available FDG avid disease tends to be resistant to RAI

PAPILLARY THYROID CANCER Lymphatic Spread High incidence if Primary > 1 cm 90 % of pts. with lateral mets. have central mets. First echelon nodes are central nodes Second echelon nodes are lateral nodes???? always

PAPILLARY THYROID CANCER Pattern of central spread 45% of unilateral tumours >1cm cm. 40% to paratracheal-24% to pretracheal 10% contralateral central 17% contralateral occult

PAPILLARY THYROID CANCER Lateral cervical spread Second echelon nodes Levels 11 to Vb Levels 11 to 1V - account for 75% mets. Levels 111 /1V most common Level 1-4% mets. ( mostly 1b ) Level Vb 16% Suboccipital and Va rare Skip lesions 8% - explanation? Occult mets. 18-60 %

WHEN TO DISSECT THE NECK Elective lateral rarely - if clin./ radiol positive nodes only Elective central - dependent on - tumour size - risk factors Of no survival advantage if micropapillary

REGIONAL RECURRENCE Overall 5-10% Highest in first 3 years 50% in first 12 months Very few after 5 years

MICROPAPILLARY THYROID CANCER If total thyroidectomy and elective neck dissection occult nodes in - central 60% - lateral 40% Rate of LN recurrence <1% - whether there is neck dissection or not -?why If total thyroidectomy and no neck dissection - most LN recurrences are ipsilateral - in levels 1V,111,11 in descending order

MEDULLARY THYROID CANCER Management of the neck is surgical alone Early detection > better survival Surgery is the only means of cure Distant spread common Survival related to resectability Therapeutic neck dissection only Elective neck dissection does not increase survival END ( lateral ) if tumour >1 cm or known central compartment disease

MICROMEDULLARY CANCER < 1 cm LN mets. at diagnosis up to 30% 1/3 multifocal Most intrathyroid >5% distant mets. 10-12% have >10 positive nodes 8% paediatric Survival overall 90% at 10 years - 50% alive at 10 years with distant mets

MICROMEDULLARY THYROID CANCER Strongest predictor of LN mets. is- - Extrathyroidal spread - Tumour size Standard of care - - Total thyroidectomy - Central dissection - Lateral dissection if Clin./ radiol. pos. nodes

LYMPH NODE ANATOMY IN THE NECK 300 Lymph Nodes on each side 50 are accessible surgically Presence of surgically inaccessible nodes at presentation assoc. with poor prognosis Main risks- - Nerve injury - Chylous leaks

LEVELS OF THE NECK

SKIN INCISIONS A matter of choice Don t cross the midline if unilateral XRT likely Avoid junctions over the carotid Save the Great auricular n. and MMB of V11

POST OPERATION Skin closure Suction drains- removal at about 4-5 days Parenteral antibiotics General medical care? Physiotherapy